OUR PURPOSEKuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies.OUR CREDENTIALSKuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team.To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing.• Listing on the SIX Swiss Exchange under the symbol KURN since 2016• A commercial & research footprint that spans >20 markets• Dozens of clinical and scientific expert advisers• >25 orthobiologics-related patents• >400 patients evaluated in Level I, randomized controlled clinical trials• >20 well-controlled Level I-IV clinical trials initiated, including 6 that are complete1• Published Level I evidence published in SpineCONTACT KUROS TO FIND OUT MORE >>>>